Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) – Identifying and Commercializing First-in-Class Innovation$6,995
- December - 2015
- In Pharmaceuticals
- By GBI Research 364 Views
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity and the fifth-leading cause of death in the world. COPD is linked to cumulative exposure to risk factors,….
Total Pages: 53